20:26:26Canada

ImageneBio, Inc. (IMA)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
800,000 -77.1%
Net income
-45,349,000
Operating income
-48,451,000
Earnings per share
-9.64
R&D expense
28,525,000

Growth and profitability

Operating margin
-6,056.38
Net margin
-5,668.63
Return on equity
-34.06
Return on assets
-29.64

Balance sheet

Total assets
152,976,000
Total liabilities
19,837,000
Shareholders' equity
133,139,000
Cash and equivalents
94,532,000
Current ratio
12.49

Cash flow and ratios

Operating cash flow
-47,844,000

Shareholder returns

Shares outstanding
12,456,281
Book value per share
10.69
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
San Diego, CA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

ImageneBio, Inc. trades on NASDAQ under the ticker symbol IMA. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis